Latest filing published 04 Jul 2022 for Medfield Diagnostics Aktiebolag, €1,306.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Claes Beckman: trading record in brief
Claes Beckman discloses dealings in Medfield Diagnostics Aktiebolag to Finansinspektionen. In total, 2 filings cover trades dated from 24 May 2021 to 23 June 2022.
The open-market record is one-sided, with 1 purchase worth €1,378 and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 4 July 2022: a transaction of €1,306, in Medfield Diagnostics Aktiebolag. The latest purchase dates back some time: it was published 1,950 days ago, on 7 July 2021. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Claes Beckman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 666 shares@ SEK 21.0048.7% of flowBTU (betald tecknad unit)ISIN SE0018040842FI:csv-41caf174041b3d584530
- 3,333 shares@ SEK 4.2051.3% of flowBTA (betald tecknad aktie)ISIN SE0015961107FI:csv-0d7e8197d3f652a504d6Canonical exit: 22 Aug 2021 (T+90)
2 of 2 declarations